Pharmaceutical giant Mallinckrodt PLC ( NYSE:MNK) has announced its intention to acquire Ikaria, a manufacturer of respiratory drugs and known for its delivery system for $2.3 billion, on Thursday. The main idea behind this acquisition is to expand its overall reach to the end users as Mallinckrodt ... ..
via News Feed
via News Feed
No comments:
Post a Comment